Purchase Order 75D30123P17227
Award Date 9/6/23
Potential Completion Date 9/6/23
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a $23,371 firm fixed-price purchase order to Illumina, Inc. for the ISEQ 100 System on August 24, 2021. The contract, which was completed by September 30, 2023, was issued without a set-aside designation, reflecting Illumina's specialized capabilities in genomic sequencing technology. The ISEQ 100 is a compact, entry-level sequencing instrument designed for targeted genomic analysis applications, supporting the CDC's...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a $27,274.50 firm fixed price purchase order to Illumina, Inc. of San Diego, California for lab supplies and MiSeq reagent kits. The contract has no set-aside designation and requires completion by October 14, 2022. The MiSeq reagent kits will support the CDC's genomic sequencing work to advance public health goals such as disease surveillance and outbreak response. Illumina will deliver the...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $68,541 purchase order to provide LLUMINA MISEQ SYSTEM REAGENTS. The firm fixed price contract has a period of performance from July 3, 2023 through August 19, 2023. Illumina will deliver its Illumina MiSeq System reagents to support the CDC's genomics and sequencing programs. No subcontractors or set aside designations were identified. The contract award utilizes the...
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $148,290.40 contract is for the provision of lab supplies, with a completion date of September 8, 2021. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing instruments, reagents, and services....
- The Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh awarded Illumina, Inc. a $46,172.80 firm fixed price purchase order for Illumina reagents. The place of performance will be Illumina's facility located in Chamblee, Georgia. The period of performance is from February 7, 2023 through August 15, 2023. CDC Pittsburgh is likely procuring the reagents to support its genomic sequencing and bioinformatics programs that help public health agencies detect,...
- The Centers for Disease Control and Prevention awarded a $1,852.50 firm fixed price purchase order to Illumina, Inc. for an Illumina NextSeq Sequencer. As the sole manufacturer of this proprietary sequencing instrument, Illumina will deliver one NextSeq Sequencer to support genomic analysis activities at the CDC's Pittsburgh location. No set-aside provision was applied to this acquisition of an Illumina sequencing system, which will aid the CDC in disease detection, surveillance, and research...
- The Centers for Disease Control and Prevention (CDC) awarded a $176,623.68 firm fixed price purchase order to Illumina, Inc. for MISEQ REAGENT KITS V3 (600 CYCLE) to be delivered to their Pittsburgh location. The place of performance for this contract is in San Diego, California. The contract period of performance is from September 11, 2023 through November 2, 2023. No subcontractors or set aside designations were identified. The CDC works to protect public health and safety through the...
- This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
- Illumina, Inc. was awarded a $11,922.64 purchase order by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh for unspecified goods or services to be delivered to San Diego, California. The award was made on a firm fixed price basis with no set-aside designation. As a manufacturer and provider of sequencing and array-based solutions, Illumina likely will supply various sequencing systems, reagents, consumables, or related bioinformatics products to...
- The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $22,376.85 contract is for the provision of an ISEQ 100 SYSTEM, with a completion date of March 1, 2026. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...